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interesting finding from these studies is that similar differentiation of 
neural progenitors to neuroepithelial cells can be induced by length-
ening of G1 phase alone.7 Is the short G1 phase a pre-requisite for 
stem cell self renewal? Data from pluripotent embryonic stem cells 
would seem to support this possibility as our own studies of human 
embryonic stem cells have shown that downregulation of a single 
Cyclin Dependent kinase (CDK2) can cause a drastic change in cell 
cycle regulation of these cells resulting in accumulation of cells in G1 
phase. The biological impacts of this are significant: cells lose the 
typical morphology of embryonic stem cells and begin to express 
differentiation specific genes.8 Even if the downregulation of CDK2 
was only transient its effect upon the cell is permanent for even though 
the cells are able to re-enter the cell cycle as the levels of CDK2 rise 
back to those normal for embryonic stem cells, the genes associated 
with the pluripotent phenotype never return to their former levels. 
Moreover, the persistent expression of differentiation associated 
genes confirms that reacquisition of a short G1 phase cannot reverse 
the differentiation marks established during the lengthening of G1 
phase.8 Similar G1 lengthening occurs during spontaneous embry-
onic stem cell differentiation and suggests that a longer G1 is perhaps 
necessary for establishment of epigenetic marks (removal of H3 and 
H4 acetylation and establishment of repressive H3K9 dimethylation 
and trimethylation, ref. 9) that are necessary for initiation of the differ-
entiation process. An essential feature of the epigenetic modifications 
that accompany differentiation is that they are largely irreversible 
therefore any gene expression profiles controlled in this manner will be 
unlikely to change when G1 shortens unless this change can somehow 
reverse epigenetic modification of the genome.
What are the molecular mechanisms that govern such fast G1 to S 
transition? Since a short G1 is linked to maintenance of pluripotency, 
it is reasonable to speculate that the core transcriptional machinery 
that underlines the pluripotent phenotype may also be responsible 
for a fast G1 to S transition in stem cells. It is now well accepted that 
three key pluripotency factors, OCT4, SOX2 and NANOG which 
are essential for propagation of undifferentiated embryonic stem cells 
work in concert to activate or repress a substantial portion of their 
target genes which are essential to maintenance of pluripotency or 
differentiated state.10 It is perhaps not surprising therefore the list of 
target genes activated by one or more of these transcription factors 
includes key players of cell cycle regulation such as CDK1, CYCLIN 
D1, CDK4, CDC7,10 suggesting direct involvement of pluripotency 
factors in the regulation of their transcription. Despite the observa-
tion that downregulation of OCT4, SOX2 and NANOG in human 
embryonic stem and carcinoma cells causes expression changes in 
a significant number of genes involved in cell cycle regulation, direct 
interaction has only recently been confirmed by our group11 when 
we showed that NANOG binds directly to the promoter region of 
CDC25A (a phosphatase involved in both G1 and G2 regulation) 
and intragenic regions of CDK6 (Cyclin Dependent kinase important 
for G1 to S transition), resulting in their transactivation. We further 
confirmed that these downstream transcriptional effectors are directly 
responsible for modulating the length of G1, thus establishing for the 
first time a direct link between length of G1,  in embryonic stem cells 
and regulators of pluripotency. This is however only the beginning 
of our understanding since a new class of regulators, microRNAs 
(miRNAs) have also been shown to regulate the length of G1 phase in 
embryonic stem cells.12 One of the most prominent miRNA clusters is 
mir-290 which is expressed in murine embryonic stem cells and shown 
to modulate G1 to S transition by repressing one of the key inhibitors, 
p21.13 Similarly, the miR-302-367 cluster which is highly expressed 
‘I reasoned that study of the cell cycle responsible for the repro-
duction of cells was important and might even be illuminating about 
the nature of life,’—Sir Paul Nurse, biochemist and identifier of Cdc2 
control of G1 to S phase progression in yeast.
The cell cycle is a collective term for the series of events taking 
place in a cell that culminates in its replication. The process comprises 
four distinct phases (G1, S, G2 and M phase) all of which are tightly 
regulated through the action of a large number of proteins including 
Cyclins and Cyclin Dependent kinases. Strictly speaking there is a fifth 
phase called G0 but since this is only populated by cells that have 
temporarily stopped dividing it is often neglected in discussions of cell 
cycle control mechanisms (reviewed in ref. 1). G1 phase (sometimes 
called Gap1) has fascinated biologists for a long time for it is during 
this stage that synthesis of various enzymes that are mostly required 
for DNA replication in S phase occurs and specification of replica-
tion origins sites that enable replication in S phase is determined.2 If 
problems arise in any of these systems then molecular checkpoints will 
prevent the cell progressing to S-phase however it is also during this 
stage that the cell makes key decision to self-renew, differentiate or die 
based on complex signaling obtained by its microenvironment. The 
duration of G1 is variable, even amongst different cells of the same 
species. G1 is particularly short in embryonic stem cells (obtained 
from preimplantation embryos) of different species including mouse, 
primates and human.3-5 The biological significance of these observa-
tions is not fully understood yet, but several key questions emerge 
from these studies and some of those are outlined below.
What is the biological significance of short G1 phase and 
does this play a role in maintenance of pluripotency? We know 
that neural progenitor cells can be divided into two subpopu-
lations based on the length of their cell cycle. Those that are 
simply undergoing mitotic proliferation have a shorter cycle than 
those committed to undergo neuronal differentiation6 but the really 
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in human embryonic stem cells and whose expression is regulated by 
OCT4, SOX2 and NANOG14 has been shown to regulate G1 to S 
transition through post translational regulation of Cyclin D2 expres-
sion.15 It must be said that the changes caused in cell cycle regulation 
by the action of miRNAs are modest compared to impacts of transcrip-
tion factors such as NANOG suggesting that miRNAs are more likely 
to act as tuners of cell cycle.
What are the implications of G1 to S transition for the induction 
of pluripotency? ‘A discovery is said to be an accident meeting a 
prepared mind.’—Albert Szent Gyorgyi (1893–1986).
Revolutionary studies in the stem cell field have shown that it is 
possible to reprogram pluripotentcy in somatic cells by overexpres-
sion of key pluripotency factors such as OCT4, NANOG, SOX2, 
LIN28, KLF4 and c-MYC. During the reprogramming process, one of 
key change that must occur is the shortening of G1 phase to a length 
more appropriate to pluripotent cells. Our own preliminary data 
(Fig. 1) suggest that changes in cell cycle are likely to happen very 
early during the reprogramming process even before the cells start to 
re-express their own pluripotency markers. Although a direct transac-
tivation of cell cycle regulators by key pluripotency factors in somatic 
cells has not been proven as yet, the short time required to increase 
the fraction of cells in S phase during the transduction of these factors 
suggest that this is likely to be a direct effect rather than a facet of 
some more general reprogramming mechanism. It is therefore likely 
that interference with cell cycle inhibitors or key tumor suppressors that 
govern the G1 to S transition may be able enhance the reprogram-
ming ability of this currently rather inefficient process. This possibility 
is supported by the enhancement of induced pluripotent cells following 
the inhibition of the regulator p53 in the absence of C-MYC expres-
sion16 and if such alternative mechanisms can be found to generate 
induced pluripotent stem cells that do not rely upon the current use 
of retroviral vectors, clinical application of this reprogramming effect 
will become a realistic possibility. Given the enormous benefits to be 
had from this work it would be surprising if the field did not develop 
rapidly but we believe that a greater understanding of the cell cycle 
dynamics of pluripotent cells can contribute in many ways towards the 
development of technologies to improve human health.
Figure 1. Increase in fraction of cells in S phase 48 hours after retroviral 
mediated overexpression of OCT4, SOX2 or NANOG in neonatal human 
dermal skin fibroblasts. Propidium iodide staining followed by flow cytom-
etry analysis (BD LSR II) is shown.
